Literature DB >> 8897182

Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management.

D Jungkind1, S Direnzo, K G Beavis, N S Silverman.   

Abstract

We evaluated the COBAS AMPLICOR (CA) PCR system (Roche Diagnostic Systems) designed for automated PCR amplification and detection of nucleic acids from infectious agents in clinical samples. The Roche AMPLICOR microwell plate (MWP) PCR was the reference method. CA amplifies target nucleic acid, captures the biotinylated amplification products by using magnetic particles coated with specific oligonucleotide probes, and detects the bound products colorimetrically. For Mycobacterium tuberculosis, the correlation of the results of CA tests with those of MWP tests was 100% with 230 samples, including 20 culture-positive samples. For hepatitis C virus, the correlation was 100% with 214 samples, including 60 positive samples. MultiPlex CA analysis of 199 cervical specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and the internal control gave 100% concordance. These samples included 19 C. trachomatis and 3 N. gonorrhoeae culture-positive samples. Overall, the agreement between PCR methods for all 842 comparisons was 100%. Compared with culture, the sensitivities of the assays for C. trachomatis and M tuberculosis were > or = 95%. After spiking alternating amplification tubes in the CA system with 10(14) copies of the Chlamydia amplicon per ml, we were unable to demonstrate any carryover cross-contamination of negative samples. Using the criteria of the College of American Pathologists workload recording method, we found that the total hands-on time to produce CA PCR results was 4.4, 7.9, and 3.3 min for M. tuberculosis, hepatis C virus, and the MultiPlexed assay for chlamydia plus gonorrhea and an internal control, respectively. The CA system brings true PCR automation to laboratories. In addition to the accuracy of automated results, the CA system provides labor savings, provides containment of the amplification and detection components of PCR, and supports both MultiPlex amplification and sequential algorithm (ReFlex) detection of analytes.

Entities:  

Mesh:

Year:  1996        PMID: 8897182      PMCID: PMC229403          DOI: 10.1128/jcm.34.11.2778-2783.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Identification of Neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction.

Authors:  M R Liebling; D G Arkfeld; G A Michelini; M J Nishio; B J Eng; T Jin; J S Louie
Journal:  Arthritis Rheum       Date:  1994-05

2.  Clinical course of acute hepatitis C and changes in HCV markers.

Authors:  K Hino; S Sainokami; K Shimoda; H Niwa; S Iino
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

3.  Simultaneous detection of three common sexually transmitted agents by polymerase chain reaction.

Authors:  S Mitrani-Rosenbaum; R Tsvieli; O Lavie; R Boldes; E Anteby; S Shimonovitch; T Lazarovitch; A Friedmann
Journal:  Am J Obstet Gynecol       Date:  1994-09       Impact factor: 8.661

4.  Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  C A Bass; D L Jungkind; N S Silverman; J M Bondi
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

5.  [Comparison of amplified Mycobacterium Tuberculosis Direct Test (MTD), Amplicor Mycobacteria kit (Amplicor) and PCR method for detection Mycobacterium tuberculosis in clinical specimens].

Authors:  M Goto; K Okuzumi; Y Sakai; S Takewaki; N Tachikawa; A Iwamoto; S Kimura; K Shimada
Journal:  Kansenshogaku Zasshi       Date:  1995-05

6.  Semiquantification by Amplicor assay of hepatitis C virus genome during therapy.

Authors:  S Navas; V Carreño
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

7.  Evaluation of Amplicor PCR for direct detection of Mycobacterium tuberculosis from sputum specimens.

Authors:  K G Beavis; M B Lichty; D L Jungkind; O Giger
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  [Efficacy of PCR-microwell plate hybridization method (Amplicor Mycobacterium) for detection of M. tuberculosis, M. avium and/or M. intracellulare in clinical specimens].

Authors:  M Aoki; T Katayama; F Yamagishi; S Yokota; K Kameda; H Saito; K Hara; T Ezaki; T Kawai; H Yotsumoto
Journal:  Kekkaku       Date:  1994-10

Review 9.  Molecular detection of hepatitis C virus: impact of detection methodology on clinical and laboratory correlations.

Authors:  M Krajden
Journal:  Crit Rev Clin Lab Sci       Date:  1995       Impact factor: 6.250

10.  Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.

Authors:  S Zeuzem; B Rüster; W K Roth
Journal:  Z Gastroenterol       Date:  1994-06       Impact factor: 2.000

View more
  31 in total

1.  Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens.

Authors:  C H Livengood; J W Wrenn
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Evaluation of three nucleic acid amplification methods for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  S X Wang; L Tay
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population.

Authors:  David J Diemert; Michael D Libman; Pierre Lebel
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Authors:  G Gerken; T Rothaar; M G Rumi; R Soffredini; M Trippler; M J Blunk; A Butcher; S Soviero; G Colucci
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

6.  Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples.

Authors:  H H Kessler; E Stelzl; R B Raggam; J Haas; F Kirchmeir; K Hegenbarth; E Daghofer; B I Santner; E Marth; R E Stauber
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

7.  Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens.

Authors:  U Reischl; N Lehn; H Wolf; L Naumann
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Comparative evaluation of two commercial assays for direct detection of Mycobacterium tuberculosis in respiratory specimens.

Authors:  F Gamboa; J M Manterola; J Lonca; L Matas; P J Cardona; E Padilla; B Viñado; J Domínguez; A Hernández; V Ausina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

9.  Evaluation of AMPLILINK software for the COBAS AMPLICOR system.

Authors:  H H Kessler; D Jungkind; E Stelzl; S Direnzo; S K Vellimedu; K Pierer; B Santner; E Marth
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

10.  Quantitative assay of hepatitis C virus RNA using an automated extraction system for specific capture with probes and paramagnetic particle separation.

Authors:  Hayato Miyachi; Atsuko Masukawa; Satomi Asai; Toshiaki Miura; Shigeru Tamatsukuri; Toru Hirose; Yasuhiko Ando
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.